Showing results (91-100 of 175) with videos related to
Sort By:
Pageof 18
JMIR Formative Research|March 31, 2022
Mobile App Intervention on Reducing the Myeloproliferative Neoplasm Symptom Burden: Pilot Feasibility and Acceptability StudyHninyee Win, Samantha Russell, Betsy C Wertheim, et al.Blood|June 7, 2019
Oral idasanutlin in patients with polycythemia veraJohn Mascarenhas, Min Lu, Heidi Kosiorek, et al.Cancer|April 12, 2023
Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasmsRaoul Tibes, Heidi E Kosiorek, Amylou C Dueck, et al.Cancer|December 22, 2005
The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia veraAyalew Tefferi, Terra L Lasho, Susan M Schwager, et al.Hematological Oncology|August 4, 2018
Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasmsTariq I Mughal, Thomas Lion, Omar Abdel-Wahab, et al.Annals of Hematology|January 13, 2025
PARADIGM-PV: a randomized, multicenter phase 4 study to assess the efficacy and safety of ropeginterferon alfa-2b in patients with low- or high-risk polycythemia veraAbdulraheem Yacoub, Ghaith Abu-Zeinah, Albert Qin, et al.Blood|November 7, 2024
Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigmAnthony M Hunter, Mrinal M Patnaik, Raphael Itzykson, et al.Clinical Lymphoma, Myeloma & Leukemia|July 16, 2019
Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL StudyMichael R Grunwald, John M Burke, David J Kuter, et al.Haematologica|January 19, 2011
The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issuesRichard A Van Etten, Steffen Koschmieder, Francois Delhommeau, et al.Leukemia & Lymphoma|September 21, 2018
Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosisKamal Menghrajani, Philip S Boonstra, Jessica A Mercer, et al.Pageof 18